{"id":1225713,"title":"DSEN Abstract: Ondansetron use in pregnancy and risk of fetal abnormalities - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-03-31","captureTimestamp":"2026-03-31T15:27:35.727000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/52249.html","snippet":"DSEN Abstract Ondansetron use in pregnancy and risk of fetal abnormalities This research was funded by the Drug Safety and Effectiveness Network (DSEN) and conducted by the following investigators: Anick Bérard, Odile Sheehy, Jessica Gorgui, Jin-Ping Zhao, Cristiano Soares de…","rawSnapshotUrl":"/api/snapshots/raw/1225713","browseUrl":"https://replay.healtharchive.ca/job-8/20260331152735/https://cihr-irsc.gc.ca/e/52249.html#ha_snapshot=1225713","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}